Michele D. Sobolewski

University of North Carolina at Chapel Hill — United States

Immunology and Microbiology · Life Sciences

18h-index2.3kcitations38works1.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(19), HIV/AIDS drug development and treatment(12), SARS-CoV-2 and COVID-19 Research(11), HIV/AIDS Research and Interventions(9), Immune Cell Function and Interaction(6)

Publications38 total

Comparison of methods to quantify inducible HIV-1 outgrowth
UNC Libraries·2025Open Access
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder Breast Cancer Patients (THRIVE 65)
Contemporary Clinical Trials·2025· 1 citedOpen Access
Addressing conceptual and design gaps in the oncology nutrition evidence base during chemotherapy: contributions of the Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes Consortium
JNCI Journal of the National Cancer Institute·2025Open Access
Nurse AMIE randomized controlled trial to address symptom management among rural advanced Cancer patients: Addressing malignancies in everyday life
Contemporary Clinical Trials·2025· 1 citedOpen Access
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA
Proceedings of the National Academy of Sciences·2024· 7 citedOpen Access
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA
2024· 2 citedOpen Access
Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody Therapy
Open Forum Infectious Diseases·2023· 1 citedOpen Access
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2–Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients
Clinical Infectious Diseases·2023· 15 citedOpen Access
Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer
Journal of Virological Methods·2023· 3 citedOpen Access
Reduction of the HIV-1 reservoir in T cells from persons with HIV-1 on suppressive antiretroviral therapy using expanded natural killer cells <i>ex vivo</i>
2022Open Access
SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization
Nature Communications·2022· 64 citedOpen Access
Potent and Broad Neutralization of SARS-CoV-2 Variants of Concern (VOCs) including Omicron Sub-lineages BA.1 and BA.2 by Biparatopic Human VH Domains
UNC Libraries·2022Open Access
Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains
iScience·2022· 2 citedOpen Access
Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains
2022· 1 citedOpen Access
Emerging SARS-CoV-2 Variants of Concern: Spike Protein Mutational Analysis and Epitope for Broad Neutralization
2021· 4 citedOpen Access
Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening
Journal of the American Medical Directors Association·2021· 32 citedOpen Access
Comparison of methods to quantify inducible HIV-1 outgrowth
Journal of Virus Eradication·2021· 11 citedOpen Access
Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy
PLoS Pathogens·2021· 64 citedOpen Access
Neutralization of European, South African, and United States SARS-CoV-2 mutants by a human antibody and antibody domains
2021· 7 cited
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study
Clinical Infectious Diseases·2021· 138 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

John W. Mellors(31), Jana L. Jacobs(15), Mary F. Kearney(13), John M. Coffin(12), Elias K. Halvas(9), Wei Shao(8), Jonathan Spindler(8), Stephen H. Hughes(8), Michael J. Bale(8), Kevin D. McCormick(8), Brian T. Luke(7), Brandon F. Keele(7), Dimiter S. Dimitrov(7), Wei Li(7), Xiaolin Wu(6), Rebecca Hoh(6), Steven G. Deeks(6), Zehua Sun(6), Benjamin R. Treat(6), Simon M. Barratt‐Boyes(6)